Ignite Creation Date:
2024-05-05 @ 9:45 PM
Last Modification Date:
2024-10-26 @ 10:08 AM
Study NCT ID:
NCT00950521
Status:
COMPLETED
Last Update Posted:
2011-04-21
First Post:
2009-07-30
Brief Title:
Efficacy Study of CD34 Stem Cell in Chronic Stroke Patients
Sponsor:
China Medical University Hospital
Organization:
China Medical University Hospital
Study Overview
Official Title:
Phase II Study of Autologous Peripheral Blood CD34 Stem Cell Implantation in Chronic Stroke Patients
Status:
COMPLETED
Status Verified Date:
2011-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The objective of the study is to determine the efficacy of brain transplants of CD34 stem cells obtained from peripheral blood of patients in the treatment of chronic stroke patients
Detailed Description:
30 patients are divided into 2 groups one treatment group and one control groupTreatment group will be implanted with peripheral blood stem cell and receive convention stroke therapy and control group only receive convention stroke therapy We expect that transplantation of the peripheral blood CD34 cells has the potential of significant benefit to neurological recovery In a previous phase I clinical trial we have shown that transplantation of CD34 cells obtained from the peripheral blood of the chronic stroke patients was safe and beneficial for neurological recovery We expect this trial can further prove the efficacy of this treatment method
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| DOH Approval No098004365 | None | None | None |